Last reviewed · How we verify
LOAd703
At a glance
| Generic name | LOAd703 |
|---|---|
| Sponsor | Lokon Pharma AB |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer (PHASE1, PHASE2)
- Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer (PHASE1, PHASE2)
- A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma (PHASE1, PHASE2)
- A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC) (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LOAd703 CI brief — competitive landscape report
- LOAd703 updates RSS · CI watch RSS
- Lokon Pharma AB portfolio CI